Resource Library

Search All Resources

  • Clear All
Alcohol Use Disorder Pharmacotherapy | April 4, 2019

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder  

Keywords: #alcohol use disorder  #pharmacotherapy  

Dr. Zeina Saliba, Medical Director of George Washington University Hospital Psychiatric Services, discusses pharmalogic options for treating alcohol use disorder, their benefits, side-effects, and risks. Dr. Saliba also shares dosage guidance.

Date added: 04/4/19

Introduction to Peer Recovery Mentors: A New Perspective in Non-Traditional Settings | March 21, 2019

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder  

Keywords: #peer mentors  #peer recovery support  

O'Nesha Cochran, a certified peer recovery mentor, shares her story and provides an overview of peer recovery support, how people interested in peer recovery can become certified, and potential barriers to peer support.

Date added: 03/21/19

Surveillance To Detect Hepatocellular Carcinoma | March 12, 2019

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hepatocellular carcinoma  #hepatology  #liver disease  #liver screening  

Incidence of hepatocellular carcinoma (HCC) is rising quickly in the United States, and AI/AN people are being affected greater than any other group. Dr. Brian McMahon, Director of the Liver Disease and Hepatitis Program at the Alaska Native Tribal Health ...

Date added: 03/12/19

The Language of Addiction | March 7, 2019

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder  

Keywords: #non-stigmatizing language  #words matter  

Dr. Karla Thornton, Professor of Infectious Diseases at the University of New Mexico Health Sciences Center, speaks about the importance of using non-stigmatizing language in substance use and shares the language recommended by the Office of National Drug Control Policy.

Date added: 03/7/19

Addressing the Evolving Opioid and HCV Epidemics | February 27, 2019

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #harm reduction  #hcv and opioids  #injection drugs  

Annette Hewitt, Nurse Practitioner for the Liver Disease and Hepatitis Program at the Alaska Native Tribal Health Consortium, explains parallels between the opioid and HCV epidemics. She also discusses harm reduction strategies that may be helpful and emphasizes the importance ...

Date added: 02/27/19

Opioid Treatment Failure | February 21, 2019

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder  

Keywords: #opioid treatment failure  #prescribing opioids  

Dr. Jonathan Robbins, an internal medicine physician at Oregon Health & Science University, speaks about the the universal precautions used in opioid prescribing, what opioid success and failure look like in primary care, and how to use a risk-benefit ratio ...

Date added: 02/21/19

Addiction Treatment and the HCV Provider | February 12, 2019

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hcv and opioids  

Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, discusses the relationship between the opioid epidemic and HCV infections as well as the different treatments available for those suffering from opioid use disorder.

Date added: 02/12/19

Medications for OUD: Who Should Get What When? | February 7, 2019

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder  

Keywords: #buprenorphine  #mat  #methadone  #naltrexone  

Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, compares buprenorphine, methadone, and extended release naltrexone in terms of efficacy, induction, retention, operational restraints, and other clinical variables when used for treating opioid use disorder.  

Date added: 02/7/19

HCV Elimination | January 23, 2019

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #cherokee hcv elimination  #hcv elimination  #micro-elimination  

Dr. Jorge Mera, Director of Infectious Diseases for the Cherokee Nation Health Service, provides a general overview of HCV elimination and micro-elimination, as well as an overview of the Cherokee Nation HCV Elimination Program.

Date added: 01/23/19

Neurobiology and Diagnosis of SUDs | January 17, 2019

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder  

Keywords: #neurobiology  #sud diagnostic criteria  

Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, reviews the diagnostic criteria for substance use disorders and examines the different ways in which substance use disorders can develop.  

Date added: 01/17/19